The Nicotinic Acetylcholine Receptor Subunit α5 Mediates Short-Term Effects of Nicotine in Vivo-Reference-Cited by-同舟云学术

The Nicotinic Acetylcholine Receptor Subunit α5 Mediates Short-Term Effects of Nicotine in Vivo

Published:2003-05-01 Issue:5 Volume:63 Page:1059-1066
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Salas Ramiro,Orr-Urtreger Avi,Broide Ron S.,Beaudet Arthur,Paylor Richard,De Biasi Mariella

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference63 articles.

1. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes.;Alkondon;J Pharmacol Exp Ther,1993

2. Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure.;Anand;J Biol Chem,1991

3. Stoichiometry of human recombinant neuronal nicotinic receptors containing the b3 subunit expressed in Xenopus oocytes.;Boorman;J Phys,2000

4. Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family.

5. Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor α-subunit

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The α4 nicotinic acetylcholine receptor is necessary for the initiation of organophosphate-induced neuronal hyperexcitability;2024-01-26

2. CHRNA5 gene variation affects the response of VTA dopaminergic neurons during chronic nicotine exposure and withdrawal;Neuropharmacology;2023-09

3. Nicotinic Acetylcholine Receptor Dysfunction in Addiction and in Some Neurodegenerative and Neuropsychiatric Diseases;Cells;2023-08-11

4. Genetic Associations with Smoking Relapse and Proportion of Follow-up in Smoking Relapse throughout Adulthood in Pre- and Postmenopausal Women;Cancer Prevention Research;2023-04-18

5. Nicotinic acetylcholine receptors and epilepsy;Pharmacological Research;2023-03